Quantification of tumor necrosis (relative to whole tumor area) showed a significant increase following VDA treatment compared to control tumors in the two p16-negative PDX models (Figure 4B, p < 0.01 for 01541; Figure 4C, p < 0.001 for 01706). The gene discussed is CDKN2A; the disease is neoplasm.